Skip to main content
. 2018 Sep 25;13:2949–2959. doi: 10.2147/COPD.S176065

Table 2.

Demographics of COPD patients by the GOLD 2011 grouping system

Total
Group A
Group B
Group C
Group D
P-value
N=1,053
(100%)
n=194
(18.4%)
n=428
(40.6%)
n=71
(6.7%)
n=360
(34.2%)
(among A, B, C, D)
Age (years) 72.8±9.6 70.7±10.1 74.6±9.6 69.8±8.6 72.5±9.2 <0.001
BMI (kg/m2) 23.4±3.9 23.8±3.3 24.0±4.1 23.0±3.5 22.5±3.8 <0.001
Male 995 (94.5%) 182 (93.8%) 400 (93.5%) 69 (97.2%) 344 (95.6%) 0.42
FEV1 1.33±0.57 1.71±0.48 1.53±0.60 1.08±0.33 0.96±0.34 <0.001
FEV1 %pred 58.5±20.5 72.4±15.3 69.0±17.2 44.9±15.1 42.0±13.1 <0.001
mMRC score 1.8±1.0 0.8±0.4 2.1±0.6 0.9±0.5 2.4±0.9 <0.001
CAT score 11.3±7.2 5.3±2.4 12.4±6.5 5.3±2.5 14.4±7.7 <0.001
Exacerbation rates 0.60±1.16 0.13±0.34 0.19±0.40 1.00±1.25 1.27±1.60 <0.001
Smoking history 0.32
 Never 97 (9.5%) 14 (7.5%) 44 (10.6%) 6 (8.7%) 33 (9.4%)
 Former 590 (57.8%) 99 (52.9%) 235 (56.6%) 43 (62.3%) 213 (60.9%)
 Pack-years 42.8±29.2 45.6±32.3 46.4±31.0 48.9±33.6 48.9±32.4
 Current 334 (32.7%) 74 (39.6%) 136 (32.8%) 20 (29.0%) 104 (29.7%)
 Pack-years 52.2±33.2 45.6±33.0 47.1±29.5 41.8±26.0 49.1±31.1

Abbreviations: FEV1, forced expiratory volume in the first second; FEV1%pred, the percentage of FEV1 of the predicted value; mMRC, modified Medical Research Council; CAT, COPD assessment test.